Ligands targeting the excitatory amino acid transporters (EAATs)

Current Topics in Medicinal Chemistry

Volumn 6, Issue 17, 2006, Pages 1897-1906

  Dunlop, John ^a   Butera, John A ^a  

^a PFIZER INC   (United States)

Author keywords

EAAT; Excitatory amino acid transporters; Glutamate

Indexed keywords

(CARBOXYCYCLOPROPYL)GLYCINE; 1 AMINO 1,3 CYCLOBUTANEDICARBOXYLIC ACID; 2 AMINO 4 [4 (2 BROMO 4,5 DIFLUOROPHENOXY)PHENYLAMINO] 4 OXOBUTANOIC ACID; 3 METHYLGLUTAMIC ACID; 4 (9H FLUOREN 2 YLAMINO) 2 AMINO 4 OXOBUTANOIC ACID; 4 METHYLGLUTAMIC ACID; [3 [4 (TRIFLUOROMETHYL)BENZOYLAMINO]BENZYLOXY]ASPARTIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; BUTYRIC ACID; DEXTRO THREO BETA BENZYLOXYASPARTIC ACID; DICARBOXYLIC ACID; DIHYDROKAINIC ACID; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; GLYCINE DERIVATIVE; HEPTANE DICARBOXYLIC ACID; HYDROXAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; LEVO ASPARTATE BETA HYDROXAMIC ACID; LEVO SERINE O SULFATE; LEVO THREO BETA BENZYLOXYASPARTIC ACID; LEVO THREO BETA HYDROXYASPARTIC ACID; N [(6 NITROCOUMARIN 7 YL)METHYL] DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NBI 59159; PYRROLIDINE DICARBOXYLIC ACID; SULFATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WAY 213613;

ASTROCYTE; BRAIN NERVE CELL; CELL MEMBRANE; CELLULAR DISTRIBUTION; DRUG STRUCTURE; DRUG TARGETING; GENE TARGETING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STRUCTURE ANALYSIS;

ASPARTIC ACID; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; GLUTAMIC ACID;

EID: 33748662208     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802606778249829     Document Type: Review

References (51)

1. Danbolt, N. C. Glutamate uptake. Prog. Neurobiol. 2001, 65(1), 1-105.
2. Bridges, R. J.; Kavanaugh, M. P.; Chamberlin, A. R. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Curr. Pharmaceut. Des. 1999, 5(5), 363-79.
3. Bridges, R. J.; Esslinger, C. S. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes. Pharmacol. Therapeut. 2005, 107(3), 271-85.
4. Shigeri, Y.; Seal, R. P.; Shimamoto, K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev. 2004, 45(3), 250-65.
5. Bergles, D. E.; Diamond, J. S.; Jahr, C. E. Clearance of glutamate inside the synapse and beyond. Curr. Opin. Neurobiol. 1999, 9(3), 293-8.
6. Fairman, W. A.; Amara, S. G. Functional diversity of excitatory amino acid transporters: ion channel and transport modes. Am. J. Physiol. 1999, 277(4 Pt 2), F481-6.
7. OShea, R. D. Roles and regulation of glutamate transporters in the central nervous system. Clin. Exper. Pharmacol. Physiol. 2002, 29(11), 1018-1023.
8. Gonzalez, M. I.; Robinson, M. B. Neurotransmitter transporters: why dance with so many partners? Curr. Opin. Pharmacol. 2004, 4(1), 30-5.
9. Dunlop, J.; Zaleska, M. M.; Eliasof, S.; Moyer, J. A. Excitatory amino acid transporters as emerging targets for central nervous system therapeutics. Emer. Therapeut. Targets 1999, 3(4), 543-570.
10. Maragakis, N. J.; Rothstein, J. D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 2004, 15(3), 461-73.
11. Balcar, V. J.; Johnston, G. A. The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J. Neurochem. 1972, 19(11), 2657-66.
12. Vandenberg, R. J.; Mitrovic, A. D.; Chebib, M.; Balcar, V. J.; Johnston, G. A. R. Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol. Pharmacol. 1997, 51(5), 809-815.
13. Eliasof, S.; McIlvain, H. B.; Petroski, R. E.; Foster, A. C.; Dunlop, J. Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systems. J. Neurochem. 2001, 77(2), 550-557.
14. 3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes. J. Neurosci. Res. 2004, 75(6), 751-9.
15. Zhou, L. M.; Gu, Z. Q.; Costa, A. M.; Yamada, K. A.; Mansson, P. E.; Giordano, T.; Skolnick, P.; Jones, K. A. (2S,4R)-4-Methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors. J. Pharmacol. Exp. Ther. 1997, 280(1), 422-427.
16. Alaux, S.; Kusk, M.; Sagot, E.; Bolte, J.; Jensen, A. A.; Brauner-Osborne, H.; Gefflaut, T.; Bunch, L. Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3. J. Med. Chem. 2005, 48(25), 7980-92.
17. Campiani, G.; Fattorusso, C.; De Angelis, M.; Catalanotti, B.; Butini, S.; Fattorusso, R.; Fiorini, I.; Nacci, V.; Novellino, E. Neuronal high-affinity sodium-dependent glutamate transporters (EAATs): targets for the development of novel therapeutics against neurodegenerative diseases. Curr. Pharmaceut. Des. 2003, 9(8), 599-625.
18. Vandenberg, R. J.; Mitrovic, A. D.; Johnston, G. A. R. Serine-O-sulphate transport by the human glutamate transporter, EAAT2. 1998, 123(8), 1593-1600.
19. Arriza, J. L.; Fairman, W. A.; Wadiche, J. I.; Murdoch, G. H.; Kavanaugh, M. P.; Amara, S. G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 1994, 14(9), 5559-69.
20. Shigeri, Y.; Shimamoto, K.; Yasuda-Kamatani, Y.; Seal, R. P.; Yumoto, N.; Nakajima, T.; Amara, S. G. Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5). J. Neurochem. 2001, 79(2), 297-302.
21. Lebrun, B.; Sakaitani, M.; Shimamoto, K.; Yasuda-Kamatani, Y.; Nakajima, T. New beta -hydroxyaspartate derivatives are competitive blockers for the bovine glutamate/aspartate transporter. J. Biol. Chem. 1997, 272(33), 20336-20339.
22. Shimamoto, K.; Lebrun, B.; Yasuda-Kamatani, Y.; Sakaitani, M.; Shigeri, Y.; Yumoto, N.; Nakajima, T. DL-threo-beta - benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol. Pharmacol. 1998, 53(2), 195-201.
23. Shimamoto, K.; Shigeri, Y.; Yasuda-Kamatani, Y.; Lebrun, B.; Yumoto, N.; Nakajima, T. Syntheses of optically pure [beta]-hydroxyaspartate derivatives as glutamate transporter blockers. Bioorg. Med. Chem. Lett. 2000, 10(21), 2407-2410.
24. Esslinger, C. S., Agarwal, S., Gerdes, J., Wilson, P. A., Davis, E. S., Awes, A. N., O'Brien, E.-O., Mavencamp, T., Koch, H. P., Poulsen, D. J., Rhoderick, J. F., Chamberlin, A. R., Kavanaugh, M. P., Bridges, R. J. The substituted aspartate analogue L-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Neuropharmacology 2005, 49850-861.
25. Sakaguchi, K.; Yamamoto, M.; Kawamoto, T.; Yamada, T.; Shinada, T.; Shimamoto, K.; Ohfune, Y. Synthesis of optically active beta-alkyl aspartate via [3,3] sigmatropic rearrangement of alpha-acyloxytrialkylsilane. Tetrahedron Lett. 2004, 455869-5872.
26. Takaoka, K.; Tatsu, Y.; Yumoto, N.; Nakajima, T.; Shimamoto, K. Synthesis and photoreactivity of caged blockers for glutamate transporters. Bioorg. Med. Chem. Lett. 2003, 13(5), 965-970.
27. Huang, Y. H., Muralidharan, S., Sinha, S. R., Kao, J. P. Y., Bergles, D. E. Ncm-D-aspartate: A novel caged D-aspartate suitable for the activation of glutamate receptors and N-methyl-D-aspartate (NMDA) receptors in brain tissue. Neuropharmacology 2005, 49831-842.
28. Shimamoto, K.; Sakai, R.; Takaoka, K.; Yumoto, N.; Nakajima, T.; Amara, S. G.; Shigeri, Y. Characterization of novel L-threo-{beta}-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol. Pharmacol. 2004, 65(4), 1008-1015.
29. Coon, T. R., Li, B., Nottebaum, L. M., Williams, J. P., Petroski, R. E., Naeve, G. S., Haddach, M., Selkirk, J. V., Jow, B., Kowal, D., Greenfield, A., Grosanu, C., Butera, J., Dunlop, J., Foster. A. C. Design and synthesis of inhibitors of the neuronal glutamate transporter EAAT3. Society for Neuroscience, 34th Annual Meeting; Poster 168.10 Oct. 23-27, 2004. 2004.
30. Greenfield, A.; Grosanu, C.; Dunlop, J.; McIlvain, B.; Carrick, T.; Jow, B.; Lu, Q.; Kowal, D.; Williams, J.; Butera, J. Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2. Bioorg. Med. Chem, Lett. 2005, 15(22), 4985-8.
31. Butera, J. A.; Greenfield, A.; Grosanu, C.; Dunlop, J.; McIlvain, H. B.; Carrick, T.; Jow, B.; Lu, Q.; Kowal, D.; Williams, J. Excitatory amino acid transporters (EAATs): I. The search for selective EAAT modulators. Abstr. Pap. Am. Chem. Soc. 230th Meeting, MEDI-41, 2005. 2005.
32. Greenfield, A.; Grosanu, C.; Dunlop, J.; McIlvain, H. B.; Carrick, T.; Jow, B.; Lu, Q.; Kowal, D.; Williams, J.; Botera, J. A. Excitatory Amino Acid Transporters (EAATs): II. Identification of potent and selective EAAT-2 inhibitors. Abstr. Pap. Am. Chem. Soc. 230th Meeting, MEDI-40, 2005. 2005.
33. Dunlop, J.; McIlvain, H. B.; Carrick, T. A.; Jow, B.; Lu, Q.; Kowal, D.; Lin, S.; Greenfield, A.; Grosanu, C:; Fan, K.; Petroski, R.; Williams, J.; Foster, A.; Butera, J. Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2. Mol. Pharmacol. 2005, 68(4), 974-82.
34. Pocock, J. M.; Murphie, H. M.; Nicholls, D. G. Kainic acid inhibits the synaptosomal plasma membrane glutamate carrier and allows glutamate leakage from the cytoplasm but does not affect glutamate exocytosis. J. Neurochem. 1988, 50(3), 745-51.
35. McMahon, H. T.; Barrie, A. P.; Lowe, M.; Nicholls, D. G. Glutamate release from guinea-pig synaptosomes: stimulation by reuptake-induced depolarization. J. Neurochem. 1989, 53(1), 71-9.
36. 3H]glutamate transport processes in rat brain. Brain Res. 1991, 544(2), 196-202.
37. Nakamura, Y.; Kataoka, K.; Ishida, M.; Shinozaki, H. (2S,3S,4R)-2-(carboxycyclopropyl) glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate. Neuropharmacology 1993, 32(9), 833-7.
38. Dunlop, J.; Lou, Z.; Zhang, Y.; McIlvain, H. B. Inducible expression and pharmacology of the human excitatory amino acid transporter 2 subtype of L-glutamate transporter. Br. J. Pharmacol. 1999, 128(7), 1485-90.
39. +-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1). Mol. Pharmacol. 1996, 49(3), 465-73.
40. Fletcher, E. J.; Mewett, K. N.; Drew, C. A.; Allan, R. D.; Johnston, G. A. Inhibition of high affinity L-glutamic acid uptake into rat cortical synaptosomes by the conformationally restricted analogue of glutamic acid, cis-1-aminocyclobutane-1,3-dicarboxylic acid. Neurosci. Lett. 1991, 121(1-2), 133-5.
41. Campiani, G.; De Angelis, M.; Armaroli, S.; Fattorusso, C.; Catalanotti, B.; Ramunno, A.; Nacci, V.; Novellino, E.; Grewer, C.; Ionescu, D.; Rauen, T.; Griffiths, R.; Sinclair, C.; Fumagalli, E.; Mennini, T. A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). New glutamate and aspartate analogues as potential neuroprotective agents. J. Med. Chem. 2001, 44(16), 2507-2510.
42. 3H]D-aspartate release by 3-hydroxy4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid, two conformationally constrained aspartate and glutamate analogs. Mol. Pharmacol. 2004, 66(3), 522-9.
43. Bridges, R. J.; Stanley, M. S.; Anderson, M. W.; Cotman, C. W.; Chamberlin, A. R. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem. 1991, 34(2), 717-25.
44. Bridges, R. J.; Lovering, F. E.; Koch, H.; Cotman, C. W.; Chamberlin, A. R. A conformationally constrained competitive inhibitor of the sodium-dependent glutamate transporter in forebrain synaptosomes: L-anti-endo-3,4-methanopyrrolidine dicarboxylate. Neurosci. Lett. 1994, 174(2), 193-7.
45. Koch, H. P.; Kavanaugh, M. P.; Esslinger, C. S.; Zerangue, N.; Humphrey, J. M.; Amara, S. G.; Chamberlin, A. R.; Bridges, R. J. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol. Pharmacol. 1999, 56(6), 1095-104.
46. 2.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake. Br. J. Pharmacol. 2003, 140(5), 839-46.
47. Bräuner-Osborne, H.; Bunch, L.; Chopina, N.; Couty, F.; Evanoa, G.; Jensen, A. A.; Kusk, M.; Nielsen, B.; Rabassoa, N. Azetidinic amino acids: stereocontrolled synthesis and pharmacological characterization as ligands for glutamate receptors and transporters Org. Biomol. Chem. 2005, 3 (21), 3926-3936.
48. Bunch, L.; Nielsen, B.; Jensen, A. A.; Brauner-Osborne, H. Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3. J. Med. Chem. 2006, 49(1), 172-8.
49. Rothstein, J. D., Chung, D. Neuroprotection with beta-lactam compounds. Patent Application WO 2005/041978-A1 2005.
50. Rothstein, J. D.; Patel, S.; Regan, M. R.; Haenggeli, C.; Huang, Y. H.; Bergles, D. E.; Jin, L.; Dykes Hoberg, M.; Vidensky, S.; Chung, D. S.; Toan, S. V.; Bruijn, L. I.; Su, Z. Z.; Gupta, P.; Fisher, P. B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433(7021), 73-7.
51. Rothstein, J. D. Novel regulation of glutamate transporter gene activation and expression by beta lactam antibiotics. Abstr. Pap. Am. Chem. Soc. 230th Meeting, MEDI-231, 2005. 2005.